Skip to content

High Frequency Chest Wall Oscillation Therapy and the possibility of its use in infants

High Frequency Chest Wall Oscillation Therapy use in infants: feasibility study for a randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-5r8v8qz
Enrollment
Unknown
Registered
2022-11-25
Start date
2022-12-20
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infant

Interventions

The study will consist on a sample of 30 infants – 10 in each group – with their respective guardians, as recommended by Whitehead et al (2016), in their study where they estimate the sample needed fo
E02.880.130

Sponsors

Faculdade de Ciências da Saúde do Trairí (FACISA) - Universidade Federal do Rio Grande do Norte (UFRN)
Lead Sponsor
Faculdade de Ciências da Saúde do Trairí (FACISA) - Universidade Federal do Rio Grande do Norte (UFRN)
Collaborator

Eligibility

Age
3 Months to 6 Months

Inclusion criteria

Inclusion criteria: Infants from 3 to 6 months old, with one of their guardians; of both sexes; born full term; without health conditions diagnoses or reflux complaints; without respiratory symptoms; which parents or guardians, greater 18 years old, authorize their participation

Exclusion criteria

Exclusion criteria: Participants (infant and guardian) who do not attend three scheduled evaluation attempts

Design outcomes

Primary

MeasureTime frame
It will be assessed the infant's sleep/wake status, presence or absence of pain using the Children and Infant's Postoperative Pain Scale (CHIPPS) and perception of comfort and acceptance of the equipment by infants and guardians through a questionnaire designed for this purpose, where there are items related to handling the equipment, observation of the infant's comfort after 5, 10 and 15 minutes during use, evaluation of the benefit of the equipment and degree of general satisfaction with the device, in addition to the perception of comfort by their guardians who will be using the equipment with the infant.

Secondary

MeasureTime frame
Respiratory rate (RR), heart rate (HR), peripheral oxygen saturation (SpO2) and pulmonary auscultation (PA) will be observed, with the RR obtained by counting the respiratory incursions for 1 minute, the HR and SpO2 will be obtained using a pulse oximeter and the pulmonary auscultation using a stethoscope positioned on the infant's chest. These measurements will be performed before, during (0, 5, 10 and 15min) and after (5, 10, 15 and 20min) the use of the equipment.

Countries

Brazil

Contacts

Public ContactKarolinne Monteiro

Faculdade de Ciências da Saúde do Trairí (FACISA) - Universidade Federal do Rio Grande do Norte (UFRN)

smkarolinne@gmail.com+55(84)33422287

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 2, 2026